Michael Grunwald, MD, is the director of Transplantation and Cellular Therapy and chief of the Leukemia Division at Atrium Health’s Levine Cancer Institute in Charlotte, N.C. He was a founding member of the team that began the leukemia and transplant programs, and is an active clinical investigator, leading trials for leukemia and transplant patients. He cares for patients with acute and chronic leukemias, including myeloproliferative neoplasms, as well as for patients receiving cellular therapies, such as blood and marrow transplants.
Dr. Grunwald participates in studies with the Blood and Marrow Transplant Clinical Trials Network and the Center for International Blood and Marrow Transplant Research. He is an editorial board member of Transplantation and Cellular Therapy and a board member of the North Carolina chapter of the Leukemia and Lymphoma Society.
Dr. Grunwald earned his bachelor’s degree at Harvard University. He went on to complete his medical degree, internship, and residency in internal medicine at The Johns Hopkins University School of Medicine, where he also completed a fellowship in hematology and medical oncology.
